A team led by Mass General Brigham researchers demonstrated that inebilizumab reduced the risk of symptoms by 87% in patients with the rare affliction known as immunoglobulin G4–related disease (IgG4- ...

University of Queensland researchers have developed a new class of oral painkillers to suppress chronic abdominal pain that is based on the peptide ...

People living with irritable bowel syndrome experience abdominal pain ... So far, most consensus reports on IBS have focused on diagnosis and treatment rather than prevention, he added. Previous ...

Newsweek spoke with three doctors about the rising rates of colorectal cancer in young people and the lifestyle changes that ...